Otsuka Medical Devices Secures First Japanese Approval for Paradise™ Ultrasound Renal Denervation System to Treat Resistant Hypertension Otsuka Medical Devices Co., Ltd. has achieved a significant regulatory milestone with the…
Turiya Anesthesia, a leading provider of high-quality anesthesia services in Southern California, is thrilled to announce the expansion of its partnership with Emanate Health to now include Foothill Presbyterian Hospital…
Spine BioPharma, Inc. announced today the Phase 3 MODEL trial (MOderate – Severe Degenerative Disc Disease Evaluation of the Lumbar Spine) evaluating SB-01, a TGF-β antagonist for intradiscal treatment of patients with Chronic Low…
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced the signing of an asset purchase agreement between Sanofi and Visirna Therapeutics, a majority-owned subsidiary of Arrowhead created to develop and commercialize four…
SimplyTest®, a leader in salivary testing solutions, and The TeleDentists, a leading provider of virtual dental care, today announced a nationwide collaboration that combines at-home oral health and pathogen testing with…
Clinisys Acquires Orchard Software Clinisys today announces the acquisition of Orchard Software from Francisco Partners, a leading global investment firm that specializes in partnering with technology businesses. The acquisition brings…
Ant Group’s AI healthcare manager, AQ, which officially launched in June 2025, has gained 100 million users following public testing that began in September 2024. Designed to support users in…
Prilenia Therapeutics B.V. and Ferrer today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the refusal of the marketing authorization for pridopidine’s marketing authorization…
Komodo Health, the Evidentiary Standard for real-world patient-journey insights and healthcare analytics, today announced a strategic partnership with Anervea.ai, an AI-native Life Sciences technology company, to accelerate innovation across Clinical…
Healthcare technology pioneer DrFirst announced today that Laizer Kornwasser, a transformative healthcare executive with a track record of driving rapid growth, has been named chief executive officer, effective July 21,…
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a bio-native AI company operating at the intersection of TechBio and next-generation drug discovery, today announced the appointment of Jeff Fried…
Biocytogen Holdings, a global biotechnology company driving drug discovery with innovative technologies, today announced it has entered into a global licensing agreement for antibody molecules with BeiGene, a global innovator…